Literature DB >> 9256623

[Effect of topically applied isopropyl unoprostone on microcirculation in the human ocular fundus evaluated with a laser speckle microcirculation analyser].

S Kojima1, T Sugiyama, I Azuma, N Konishi, H Fujii.   

Abstract

The effect of topically applied 0.12% isopropyl unoprostone (unoprostone, Rescula) on the circulation of optic nerve head (ONH) and choroid-retina was studied using a laser speckle tissue circulation analyser in 9 normal human eyes. Normalized blur (NB), a quantitative index of blood flow velocity, was measured every 0.125 sec and averaged over 5 pulses in the temporal site of ONH free of surface vessels and in the middle site of the choroid-retina between ONH and macula. Intraocular pressure (IOP), blood pressure (BP), and pulse rate (PR) were also measured. On the first day, NB, IOP, BP, and PR were measured before and every 90 minutes for 6 hours after a 30 microliters instillation of placebo in both eyes (control eyes). The measured values were used as controls. On the other day one week later, a 30 microliters instillation of unoprostone was performed in one randomly chosen eye and the placebo in the other eye (treated and untreated eye). The above parameters were measured as the first day in a double masked manner. In the control experiment, no significant change occurred in any parameter. After topical application of unoprostone, NB in ONH showed no significant change. NB in the choroid-retina significantly increased at 3 (8%) and 4.5 (11%) hours in the treated eyes compared with the control eyes. After topical application of unoprostone, the IOP significantly decreased at 1.5 and 4.5 hours in the treated eyes compared with the control eyes. BP and PR showed no significant change. These results suggest that instillation of unoprostone can increase blood flow in the choroidretna in human eyes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256623

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  6 in total

1.  Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.

Authors:  A Hommer; B Kapik; N Shams
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

2.  Vasodilatory mechanisms of unoprostone isopropyl in isolated porcine retinal arterioles.

Authors:  Ichiro Tanano; Taiji Nagaoka; Shinji Ono; Tsuneaki Omae; Shinichi Otani; Akitoshi Yoshida
Journal:  Mol Vis       Date:  2015-06-12       Impact factor: 2.367

3.  Effect of topical isopropyl unoprostone on macular atrophy progression in eyes with exudative age-related macular degeneration.

Authors:  Chieko Shiragami; Masahiro Miyake; Atsushi Fujiwara; Yuki Morizane; Akitaka Tsujikawa; Ayana Yamashita; Fumio Shiraga
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Recent advances in pharmacotherapy of glaucoma.

Authors:  S K Gupta; Galpalli Niranjan D; S S Agrawal; Sushma Srivastava; Rohit Saxena
Journal:  Indian J Pharmacol       Date:  2008-10       Impact factor: 1.200

Review 5.  Safety of unoprostone isopropyl as mono- or adjunctive therapy in patients with primary open-angle glaucoma or ocular hypertension.

Authors:  Paulo Augusto de Arruda Mello; Natalia C Yannoulis; Reza M Haque
Journal:  Drug Saf       Date:  2002       Impact factor: 5.228

6.  MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION.

Authors:  Yukari Takasago; Chieko Shiragami; Mamoru Kobayashi; Rie Osaka; Aoi Ono; Ayana Yamashita; Akitaka Tsujikawa; Kazuyuki Hirooka
Journal:  Retina       Date:  2019-02       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.